Reactivated ATF3 suppresses CRC proliferation and survival by downregulating Bcl-2, upregulating p21 (<i>CDKN1A</i>) to induce cell cycle arrest, promoting caspase-3-mediated apoptosis, and inhibiting PI3K-Akt signaling. This evidence concerns the gene BCL2 and colorectal carcinoma.